Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Ikena Oncology, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Robert Lally, Senior Vice President (Form 8-K filed 2026-06-26). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Bvf Partners L P/Il (filed 2026-08-14).
Who is behind it
ImageneBio, Inc.: incorporated in Delaware; business address in San Diego, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- Mark Manfredi: Executive Officer, Director (Form D, 2025-07-18)
- Jotin Marango: Executive Officer (Form D, 2025-07-18)
- Jeffrey Ecsedy: Executive Officer (Form D, 2025-07-18)
- David Bonita: Director (Form D, 2025-07-18)
- Iain Dukes: Director (Form D, 2025-07-18)
- Jean-Francois Formela: Director (Form D, 2025-07-18)
- Otello Stampacchia: Director (Form D, 2025-07-18)
- Maria Koehler: Director (Form D, 2025-07-18)
- Richard Wooster: Director (Form D, 2025-07-18)
- Owen Hughes: Director (Form D, 2025-07-18)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Bvf Partners L P/Il | 9.9% |
| Schedule 13G/A, 2026-05-15 | Bvf Partners L P/Il | 9.9% |
| Schedule 13G/A, 2026-05-14 | Blue Owl Capital Holdings LP | 8.51% |
| Schedule 13D/A, 2026-04-29 | Orbimed Advisors LLC | 13.1% |
| Schedule 13G, 2026-04-21 | Trails Edge Capital Partners, LP | 9.9% |
| Schedule 13D, 2026-04-21 | Omega Fund Vi, L.P. | 8.4% |
| Schedule 13G/A, 2026-02-13 | Deep Track Capital, LP | 0% |
| Schedule 13G, 2026-02-12 | Blue Owl Capital Holdings LP | 7.37% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-26 | Robert Lally | Senior Vice President | departed | 2026-07-22 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-07-18 | $0 | $75M |
| Form D, 2023-08-18 | $42.57M | $42.57M |
Latest IPO step: ImageneBio, Inc. filed to go public (S-1, 2025-09-08).
IPO filings: S-1, 2025-09-08; ticker IMA on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/imagenebioLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2025-07-18 · Form 8-K, 2026-06-26 · S-1, 2025-09-08
Who owns ImageneBio, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/imagenebio